Latest News

G+FLAS Life Sciences, a Korean CRISPR/Cas Genome Editing Company, Licenses DNA-Free Genome Editing Technologies

SEOUL, South Korea–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/CRISPR?src=hash" target="_blank"gt;#CRISPRlt;/agt;–G+FLAS Life Sciences announced that they licensed two patents regarding Non-GMO ways of plant genome engineering. Source link...

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy


COVID-19 (Coronavirus) is a new illness that is having a major effect on all businesses globally LIVE COVID-19 STATISTICS FOR World